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ABSTRACT

Expression of ALK protein by lymphoid cells and the description of variant
anaplastic lymphoma kinase (ALK) translocations have typically been restricted to cases of T cell and null anaplastic large cell lymphoma (ALCL). All such cases result from a novel fusion created by the ALK gene on chromosome 2p23 and NPM on 5q35 or other variant translocation partners. A rare variant of diffuse large B cell lymphoma (DLBCL), originally described in 1997, was thought to over-express full-length ALK in contrast to a chimeric protein characteristic of ALCL. However, full-length ALK protein lacks tyrosine kinase activity and thus the mechanism of oncogenesis has remained elusive.
We describe six cases of ALK + DLBCL characterized by a simple or complex t(2;17)(p23;q23) involving the clathrin gene (CLTC) at chromosome band 17q23 and the ALK gene at chromosome band 2p23. All cases were studied using fluorescence in-situ hybridization (FISH), complemented in one case with standard cytogenetic analysis, multi-color karyotyping (M-FISH) and RT-PCR.
These results clearly demonstrate that the majority of cases of ALK + DLBCL share the same mechanism of deregulated ALK expression. Moreover, these results demonstrate the presence of CLTC-ALK fusions in these tumors and extend the list of diseases associated with this genetic abnormality to include classical T cell or null ALCL, ALK + DLBCL and inflammatory myofibroblastic tumors.
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INTRODUCTION
Anaplastic large cell lymphoma (ALCL) is a well-defined subtype of nonHodgkin's lymphoma (NHL) with characteristic morphological features, immunophenotype and molecular genetic alterations 1 . ALCL is of T cell or null phenotype, positive for CD30, frequently expresses cytotoxic granule proteins and in the majority of cases, ALK protein 2, 3 . Most cases are characterized by the t(2;5)(p23;q35), which results in a fusion between the anaplastic lymphoma kinase (ALK) gene at chromosome band 2p23 and nucleophosmin (NPM) at chromosome band 5q35 4 . Several variant translocations have now been described, including the t(2;17)(p23;q23) involving the clathrin gene (CLTC) at 17q23 5, 6 . The initial report of this variant translocation in ALCL identified the clathrin-like gene (CLTCL) at band 22q11 rather than the CLTC gene as the ALK partner, due to an error in GenBank. Subsequently it was established that the clathrin-like sequence was in fact clathrin, corresponding to a t(2;17)(p23;q23), rather than the previously assumed t(2;22)(p23;q11). The clathrin gene encodes a coated vesicle protein involved in the intracellular transport of various molecules.
In 1997, a series of seven cases of an unusual variant of diffuse large B cell lymphoma (DLBCL) was described that appeared to express full-length ALK protein, rather than the typical NPM-ALK fusion 7 . 8, 9 . Although the majority of ALK rearrangements have only been described in ALCL, four (TPM3-ALK, TPM4-ALK, RANBP2-ALK and CLTC-ALK) have been implicated in the pathogenesis of IMTs 5, 10 . In this report we describe the presence of the CLTC-ALK fusion in a series of six cases of ALK + DLBCL, extending the list of diseases with this translocation involving the ALK gene.
Although this study cannot exclude a role for deregulated expression of fulllength ALK in some cases, it firmly establishes a role for the CLTC-ALK fusion in the pathogenesis of ALK + DLBCL. were selected as telomeric and centromeric probes flanking the CLTC locus, respectively. For the dual-color FISH assay flanking the CLTC locus, clones were differentially labeled with Texas Red (TR, telomeric) and Spectrum Green (SG, centromeric). As break apart assay for the ALK locus, the commercially available LSI-ALK probe was applied (ALK telomeric in Spectrum Orange and ALK centromeric in SG; Vysis, Downers Grove, IL, USA). For the multicolor interphase assay flanking both ALK and CLTC, the commercial LSI-ALK probe was combined with the CLTC clones, the latter being labeled with TR (telomeric) and diethylaminocoumarin (DEAC, centromeric). Bacterial cultivation, BAC DNA isolation and labeling and probe preparation were performed as previously 
Cell Lines, RNA Extraction and RT-PCR:
The SU-DHL-1 and RH30 cell lines were kindly provided by Dr ML Cleary recommendations. Synthesis of the first cDNA strand was performed as previously described, using an ALK specific primer 6 . CLTC-ALK transcripts were detected by RT-PCR as previously described, using the primers ALK1 and CLA1 in the first round, followed by a nested PCR with the inner primer pair ALK2/CLA3, yielding a 270 bp product 6 .
ALK transcripts corresponding to the ALK extracellular domain were detected by two rounds of RT-PCR. The first step consisted of an ALK gene-specific reverse transcription at 48°C for 45 minutes, followed by 30 cycles comprising a denaturation step at 94°C for 45 seconds, an annealing step at 68°C for 45 seconds, and an elongation step at 72°C for 45 seconds. The first round of PCR was performed using ALK-EC1 (5'-CCATCTCCTTCTCCTGATTATTTT-3') and ALK-EC2 (5'-CACTGCAGACAAGCTGCGGTT-3') primers. The second round was performed on a 2 µl aliquot from the first amplification, using nested primers ALK-EC int1 (5'-ATGACCTCAGGAACCAGAGCTGGTCC-3') and ALK-EC int2 (5'-CCAACCATGCTTCCCTGGAGTGG -3'), yielding a 317 bp product.
RESULTS
Clinical, Histological, and Immunophenotypic Findings:
The incidence of ALK + DLBCL is unknown and cannot be estimated with confidence from this study. The reported cases represent uncommon DLBCL cases from the consultative files of several of the authors, and thus are heavily influenced by both selection and referral bias. Nonetheless, a small study of ALK expression using a tissue microarray of 120 de novo DLBCL patients from British
For personal use only. on October 17, 2017. by guest www.bloodjournal.org From 9 Columbia failed to detect any ALK-positive cases, suggesting a frequency of < 1% of DLBCL (RDG and GD, unpublished observations). The details of all six cases included in the study are described in Table 1 The immunophenotypic results in all six cases were also similar. All six cases lacked expression of pan-B cell antigens CD20 and CD79a. CD138 was strongly positive in all cases, as was epithelial membrane antigen (EMA) (see Table 1 ).
Four cases showed light-chain restriction with expression of lambda, and three of these also expressed IgA heavy chains. In two cases immunoglobulin expression was technically not interpretable, however one of these (case # 1) showed a distinct clonal IGH rearrangement using consensus PCR strategies for framework one and J-region gene segments (data not shown). CD30 was negative in all six cases, highlighting the distinction from ALCL. The expression of Bcl-2 protein was assessed in four cases with all four being negative. Weak, focal expression of CD4 was seen in two cases and CD57 in a single case, but CD3 was negative in all cases. The pattern of ALK expression was identical in all six cases. ALK protein expression was restricted to the cytoplasm and showed a fine granular pattern in all cells (see Fig. 1 ). In addition, some cases showed membrane reinforcement of ALK staining.
Cytogenetic, M-FISH and Dual/Multicolor Interphase FISH:
Cytogenetic analysis was available for case # 1 only. This showed a complex karyotype with an add(2)(p23) and add(17)(q23). Locus-specific FISH with the dual colored ALK probe confirmed a breakp oint resulting in splitting apart of the ALK gene flanking probes (see Fig. 2 insert) Interphase cytogenetic analyses with dual-color probes flanking the ALK and CLTC loci were performed on formalin-fixed, paraffin-embedded tissue sections of the five evaluable DLBCL cases. In case # 5, only old unstained sections were available, resulting in poor probe hybridization that prevented reliable evaluation.
This case was not studied by FISH, but was analyzed using RT-PCR (see Table   1 ). The other five cases displayed a split of the signals flanking ALK and CLTC, respectively, indicating a chromosomal breakpoint within both loci (Figure 3) . In order to confirm the presence of a t(2;17)(p23;q23) translocation leading to CLTC-ALK fusion, a four-color interphase FISH assay was applied (Figure 3 ). In three cases (case # 1, 2 & 6), fusion of the CLTC-centromeric (5') and ALK - Remarkably, the ALK-centromeric (5') and CLTC-telomeric (3') 
RT-PCR:
Detection of hybrid CLTC-ALK transcripts
Our RT-PCR technique showed that a 270 bp CLTC-ALK band could be amplified from two cases (Fig 4a, For
Detection of ALK transcripts
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